Fen Huang, Xiangzong Zeng, Zhiping Fan, Na Xu, Sijian Yu, Li Xuan, Hui Liu, Hua Jin, Ren Lin, Pengcheng Shi, Ke Zhao, Xiaofang Li, Xiaolei Wei, Jun Xu, Zhixiang Wang, Jing Sun, Yanyan Chai, Qifa Liu
To compare the outcomes between peripheral blood stem cell (PBSC)+cord blood and PBSC+bone marrow (BM) grafts in the setting of haploidentical donor (HID) transplantation, 110 patients were enrolled in this retrospective study, including 54 recipients of haplo-PBSC+cord transplants and 56 recipients of haplo-PBSC+BM transplants. Chimerism analyses revealed that by day 30 post-transplantation, 94.3% of surviving patients in the haplo-PBSC+cord group had achieved full haploidentical chimerism and 5.7% had <10% cord chimerism, whereas 100% of surviving patients in the haplo-PBSC+BM group had achieved full donor chimerism...
December 2022: Transplantation and cellular therapy